Safety and efficacy of antigen-specific regulatory T-cell therapy for patients with refractory Crohn's disease.
暂无分享，去创建一个
A. Foussat | M. Ticchioni | P. Desreumaux | X. Hébuterne | L. Beaugerie | M. Allez | Y. Bouhnik | J. Colombel | V. Brun | N. Belmonte | M. Nachury | M. Forte | Hervé Bastian | V. Neveu | N. Clerget-Chossat | P. Morel-Mandrino | A. Duchange | Miguel Forte | X. Hébuterne